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Summary. The adult small and large intestines display 
distinct expression profiles of Bcl-2 homologs, known 
regulators of apoptosis. This is thought to indicate that 
control mechanisms of intestinal apoptosis are gut 
segment-specific. Little is known on the expression of 
Bcl-2 homologs during gut development. In man, 
intestinal features and functions are acquired largely by 
mid-gestation (18-20 wks); the question whether 
segment-specific controls of intestinal apoptosis are also 
acquired early during development remains open. In the 
present study, we approached this by investigating the 
expression of six Bcl-2 homologs (Bcl-2, Bcl-XL, Mcl- 
1, Bax, Bak, Bad), and one nonhomologous associated 
molecule (Bag-1), during development of the human 
ileum and colon (12-20 wks of gestation). Beginning at 
18 wks, we found that the epithelial localization of Bcl-2 
homologs displayed differential patterns (or gradients) in 
both the ileum and colon; however, the patterns of some 
of the homologs differed between the two segrnents. For 
instance, Bag-1 and Bcl-2 exhibited crypt-villus 
decreasing gradients of expression in the ileum but not 
in the colon, whereas Mcl-1 displayed differing 
compartimentalizations between the two segments. 
Further analyses indicated that the steady-state 
expression levels of Bcl-2 homologs underwent 
modulations between 12 and 20 wks; however, the 
obsewed developmental profiles contrasted significantly 
between the two segments. For example, Bcl-2, Bag-1 
and Bak levels increased in the colon, but the levels of 
these same homo.logs decreased in the ileum. 
Furthermore, by 18-20 wks, we found that the 
expression levels of each Bcl-2 homolog analyzed 
differed greatly between the ileum and colon. 
Altogether, these data indicate that the expression of 
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Bcl-2 homologs is modulated differentially during 
human gut development in order to establish, by mid- 
gestation, distinct expression profiles for the small and 
large intestines. This in turn suggests that gut segment- 
specific control mechanisms of human intestinal 
apoptosis are acquired early during fetal life. 
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lntroduction 
Although originating from the same tube-like 
primitive gut, the adult human small and large intestinal 
mucosae differ in organization and physiological 
functions. The small intestine is characterized by its 
crypt-villus axis, where epithelial cell production occurs 
in small crypts and differentiated cells line along lumen- 
projecting villi, whereas the colon is characterized by 
gland-like crypts and a lack of villi, the differentiated 
cells constituting instead a 'surface' epithelium 
(Leblond, 1981; Ménard, 1989; Cobb and Williamson, 
1991; Ménard and Calvert, 1991; Ménard and Beaulieu, 
1994; Jones and Gores, 1997; Potten, 1997). The 
predominant physiological role of the colon epithelium 
is to regulate luminal fluid and electrolyte contents, 
whereas that of the small intestine's lie in the digestive 
process and absorption of nutrients (Ménard, 1989; 
Binder et al., 1991; Cobb and Williamson, 1991; Ménard 
and Calvert, 1991; Ménard and Beaulieu, 1994). 
Within the context of the rapid, continuous cell 
renewal of the intestinal epithelium, apoptosis is the 
normal fate of villus-tip cells in the small intestine, and 
of surface celis in the colon (Moss and Holt, 1996; Jones 
and Gores, 1997; Potten, 1997; Barkla and Gibson, 
1999). In the gut, as in other tissues, it is necessary for 
apoptosis to be highly regulated, in order to ensure 
proper tissue homeostasis (Potten, 1992; Thompson, 
Bcl-2 homologs in the developing human gut 
1995; White, 1996; Jacobson et al., 1997). Among the 
genes regulating apoptosis, the Bcl-2 family of proteins 
governs a critica1 checkpoint regulating the common 
downstream effector pathway of programmed cell death 
(Reed, 1994; White, 1996; Adams and Cory, 1998; Saini 
and Walker, 1998). At least 15 family members have 
been identified so far, functioning either as anti- 
apoptotic or pro-apoptotic regulators. Bcl-2 homologs 
are well known to interact among themselves, as well 
with an expanding repertoire of associated molecules 
(e.g. Bag-1), aliowing for the titration of pro- and anti- 
apoptotic functions (Farrow and Brown, 1996; Reed et 
al., 1996a,b; Adams and Cory, 1998). 
A role for some Bcl-2 homologs (namely Bcl-2, Bcl- 
X Mcl-1 and Bak) has been proposed in the regulation 
okPoptosis in the epithelium of the human adult srnall 
and large intestines, a potential function well illustrated 
by their differential pattems (or gradients) of expression 
between the undifferentiated (crypt) and differentiated 
cell compartments (Hockenbery et al., 1991; Lu et al., 
1993; Krajewski et al., 1994c, 1995, 1996; Krajewska et 
al., 1996; Moss et al., 1996; Liu et al., 1999). Intestinal 
physiopathologies that involve dysregulation of 
apoptosis further underlie distinctions between the small 
intestine and colon. Indeed, numerous such disorders 
exhibit epidemiological characteristics that appear to be 
bowel segment-specific (Ahnen, 1991; Janowitz and 
Mauer, 1991; Mendeloff, 1991; Kagnoff, 1995; Stenson, 
1995). An example of this is cancer, which is extremely 
rare in the small intestine as opposed to the colon 
(Ahnen, 1991; Mendeloff, 1995). To this effect, there is 
accumulating evidence which indicates that the epithelial 
expression profiles of Bcl-2 homologs differ between the 
adult small intestine and colon (Hockenbery et al., 1991; 
Lu et al., 1993; Krajewski et al., 1994a-c, 1995, 1996; 
Merritt et al., 1995; Krajewska et al., 1996; Wilson and 
Potten, 1996; Hirose et al., 1997; Wiison et al., 2000). 
Such differences are thought to reflect differential 
segment-specific control mechanisms of enterocytic 
apoptosis and may also account (at least in part) for the 
apparent segmental preferentes of bowel disorders that 
involve apoptosis dysregulation (Potten, 1992, 1997; 
Jones and Gores, 1997). 
However, little is known on the epithelial expression 
of Bcl-2 homologs during human gut development. The 
morphogenesis of the intestinal mucosa has been the 
subject of many reviews (Ménard, 1989; Cobb and 
Williamson, 1991; Ménard and Calvert, 1991; Ménard 
and Beaulieu, 1994). In man, intestinal architectural 
features and functions are acquired early during fetal life 
(Ménard, 1989; Ménard and Calvert, 1991; Ménard and 
Beaulieu, 1994). Villus formation by mesenchymal 
infiltration of the stratified epithelium begins around 8-9 
wks of gestation, proceeding distally until around 12 
wks when the entire intestine is lined by short villi 
covered by a simple columnar epithelium. By mid- 
gestation (18-20 wks), al1 of the gut mucosa,-from 
duodenum to colon, is organized into a functional crypt- 
villus axis which is highly similar to that of the adult 
small intestine, including digestive capacities and 
dynamic epithelial cell renewal (Ménard, 1989; Ménard 
and Calvert, 1991; Ménard and Beaulieu, 1994). To this 
effect, we have previously shown that intestinal 
epithelial apoptosis is absent between 12 and 17 wks, 
whereas by mid-gestation villus-tip apoptosis has 
emerged and is consistently obsewed thereafter (Vachon 
et al., 2000). Finally, between 30 wks and birth, the 
colon loses its villi and its digestive enzyme activities 
diminish, or disappear (Ménard, 1989; Cobb and 
Williamson, 1991; Ménard and Calvert, 1991; Ménard 
and Beaulieu, 1994). Therefore, the question remains 
open as to whether segment-specific control mechanisms 
of enterocytic apoptosis are also acquired early during 
human gut development. 
In the present study, we approached this question by 
examining the epithelial expression and localization of 
six Bcl-2 homologs (Bcl-2, Bcl-Xv Mcl-1, Bax, Bak, 
Bad), and one nonhomologous associated molecule (Bag- 
l), during the development of the human ileum and colon 
between 12 and 20 wks of gestation. Herein, we find that 
al1 homologs analyzed are expressed throughout 
morphogenesis of the two adjacent bowel segments; 
however, the developmental expression profiles of some 
of the homologs studied contrasted significantly between 
the ileum and colon. Furthermore, by 18-20 wks, 
differences are obsewed between the two segments in the 
crypt-viilus localization of Bcl-2 homologs, as well as in 
their relative epithelial expression levels. Hence, these 
data altogether indicate that the expression of Bcl-2 
homologs is modulated differentially during human gut 
development in order to establish, by mid-gestation, 
distinct epithelial Bcl-2 homolog expression profiles for 
the small and large intestines. 
Materials and methods 
Ticsue processing 
Human fetal ileum and colon (proximal, median, 
distal) specimens from 42 fetuses ranging from 12 to 20 
weeks of age (post-fertilization) were obtained after 
therapeutic termination of pregnancy. Only specimens 
obtained rapidely (60 min or less) were used. The 
present study was in accordance with a protocol 
approved by the institutional Human Research Ethical 
Review Committee for the use of human biological 
materials. 
For immunolocalization studies, tissues were washed 
in PBS (pH 7.4) and embedded in OCT (Optimum 
Cutting Temperature) compound (Tissue Tek, Miles 
Laboratories, Elkhart, IN), as previously described 
(Beaulieu et al., 1991; Perreault et al., 1995; Vachon et 
al., 2000). For analyses of protein expression levels, 
mucosal scrappings (Beaulieu et al., 1993; Beaulieu and 
Vachon, 1994; Vachon et al., 2000) of samples were 
washed in PBS (pH 7.4) and homogenized in 20 mM 
Tris-HC1 (pH 6.8) containing 0.1 mM phenyl- 
methylsulfonyl fluoride (PMSF), 50 pglml leupeptin, 50 
Bcl-2 homologs in the developing human gut 
pglml antipain, and 0.1 mg/ml aprotinin. Note that 
mucosa1 scrappings separate al1 of the mucosa from the 
presumptive/developing outer muscular layers (Beaulieu 
et al., 1993; Beaulieu and Vachon, 1994; Vachon et al., 
2000). Total proteins were measured using the BioRad 
(Hercules, CA) protein assay. Aiiquots of homogenates 
were directly solubilized in 2x solubilization buffer 
(2.3% [wlv] SDS, 10% [v/v] glycerol, and 0.001% [w/v] 
bromophenol blue in 62.5 mM Tris-HC1 [pH 6.81 
containing 5% [v/v] B-mercaptoethanol), boiled (105 "C, 
5 min), cleared by centrifugation (13000g, 5 min, room 
temperature), and processed for storage as described 
(Vachon et al., 1995,1996,2000). 
Anübodies 
Primary rabbit polyclonal antibodies used in the 
present study were Ab 1682, directed against human 
Mcl-1 (Krajewski et al., 1994a, 1995); Ab 1695, directed 
to human/mouse Bcl-XL (Krajewski et al., 1994~); Ab 
1701 (Krajewski et al., 1994a) and Ab PC68 
(Calbiochem, San Diego, CA), both directed against 
human Bcl-2; Ab 1712 (Krajewski et al., 1994b) and Ab 
PC66 (Calbiochem), both directed to human Bax; Ab 
1764, directed against human Bak (Krajewska et al., 
1996; Krajewski et al., 1996); Ab 1-19 (Santa Cruz 
Biotech., Santa Cruz, CA), directed to humanlmouse 
Bak; Ab PC67 (Calbiochem), directed to human Bcl-XL, 
Ab K-20 (Santa Cruz Biotech.), directed against 
human/mouse Mcl-1; and Ab 9292 (New England 
Biolabs, Beverly, MA) and Ab R-20 (Santa Cruz 
Biotech.), both directed to human Bad. Primary mouse 
monoclonals used were mAb K56C8 (Takayama et al., 
1995; Wang et al., 1996), directed against human Bag-1; 
mAb 32 and mAb 48 (both from Transduction 
Labs./Biocan Scientific, Mississauga, ON, Canada), 
directed to human Bad; and mAb CY-90 (Sigma-Aidrich 
Canada Ltd., Oakville, ON), directed against human 
cytokeratin 18 (K18). Note that antibodies Ab1682, 
Ab1695, Ab1701, Ab1712, Ab1764 and mAb K56C8 
were developed in the.laboratory of one of the authors 
(J.C.R.) of the present study and have been characterized 
extensively in previous studies (Krajewski et al., 1994a- 
c, 1995, 1996; Takayama et al., 1995; Krajewska et al., 
1996; Moss et al., 1996; Wang et al., 1996; Liu et al., 
1999; Boucher et al., 2000; Vachon et al., 2000). 
Immunolocalization analyses 
Cryosections (4-6 pm thick) of human fetal ileum 
and colon samples were fixed and stained by indirect 
immunofluorescence as described previously (Beaulieu 
et al., 1991; Beaulieu and Vachon, 1994; Perreault et al., 
1995; Vachon et al., 2000). Rabbit antisera were used at 
1 : 100-1:1000 dilutions, and mouse monoclonals were 
used at 1:50-1:1000 dilutions. Al1 dilutions were made in 
PBS (pH 7.4) containing 5% (wlv) non fat powdered 
milk. FITC-conjugated goat anti-rabbit or anti-mouse 
IgG (Roche Diagnostics/Boehringer Mannheim, Laval, 
QC, Canada) were used as secondary antibodies. 
Sections were counterstained with 0.01% (wlv) Evans 
blue in PBS (pH 7.4), mounted in glycerol-PBS (9:l) 
containing 0.1% (w/v) paraphenylenediamine, and 
viewed with a Reichart Polyvar 2 microscope (Leica, St- 
Laurent, QC, Canada) equipped for epifluorescence. In 
al1 cases, no specific immunofluorescent staining was 
observed when primary antibodies were omitted or 
replaced by nonimmune (rabbit or mouse) serum (not 
shown). Al1 immunofluorescent micrographs shown 
herein are representative of at least three (m 3) different 
specimens for each developmental stage analyzed. 
Analyses of protein expression levels 
Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) on 15% (wlv) acrylamide 
Tris-HC1 gels (Biorad) was performed as described 
previously (Vachon et al., 1996, 1997, 2000). Broad 
range molecular mass markers (6.8-209 kD range; 
Biorad) were used as standards. Total proteins (50 
pglwell) were separated by electrophoresis and then 
electrotransferred to nitrocellulose membranes 
(Supported NitroCellulose-1; Life Technologies/Gibco- 
BRL, Burlington, ON, Canada) for subsequent 
immunoblotting (Vachon et al,, 1996, 1997, 2000). 
Rabbit antisera were used at 1:200-1:2000 dilutions, and 
mouse monoclonals were used at 1:100-1:5000 dilutions. 
immunoreactive bands were visualized by the enhanced 
chemiluminescence method (ECL system; 
Amersham/Pharmacia Biotech., Baie DYUrfé, QC, 
Canada) according to the manufacturer's instmctions. 
To characterize the developmental epithelial 
expression profiles of Bcl-2 homologs in relation to 
morphogenesis of the ileum and colon, relative epithelial 
expression levels were evaluated by comparison with a 
reference protein, cytokeratin 18 (K18). This epithelial 
cytoskeletal component is expressed in the intestinal 
epithelium at constant levels throughout the 
development of the gut (Beaulieu et al., 1993; Vachon 
and Beaulieu, 1995; Vachon et al., 1995, 2000). Band 
intensities were quantified by laser densitometry using 
an Alpha Imager 1200 Documentation and Analysis 
system (Alpha Innotech Corp., San Leondro, CA). Total 
peak areas (AU x mm) were determined at 12-14,15-16, 
17-18 and 19-20 weeks of gestation in order to establish 
the ratios homolog/K18 for each molecule studied. 
Values shown represent mean r SEM of at least three 
different specimens (nr 3) per developmental age group 
for each gut segment analyzed; statistically significant 
(0.001s ps  0.01) differences were determined with the 
Student t test. 
Results 
To ascertain whether segment-specific control 
mechanisms of enterocytic apoptosis are acquired early 
during human gut development, we examined the 
epithelial expression and localization of Bcl-2 homologs, 
Bcl-2 homologs in the developing human gut 
acknowledged central regulators of programmed cell 
death, during morphogenesis of the ileum and colon. 
Epithelial localization of Bcl-2 homologs during 
development of the ileum and colon: similarities and 
differences 
Using specific antibodies, we first investigated by 
immunofluorescence the presence and localization of six 
Bcl-2 homologs and one associated molecule (Bag-1) in 
cryosections of human fetal ileum and colon specimens, 
aged between 12 and 20 wks of gestation. Of the Bcl-2 
homologs studied, three are known for their anti- 
apoptotic functions (Bcl-2, Bcl-XL, Mcl-1) and three 
others are pro-apoptotic regulators (Bax, Bak, Bad); 
also, the Bag-1 protein functions as an anti-apoptotic 
molecule (Wang et al., 1994, 1996; Takayama et al., 
1995; Reed et al., 1996a,b; Adams and Cory, 1998). To 
our knowledge, there has been no report of Bag-1, Bax 
or Bad expression in the human ileum, or of Bag-1 and 
Bad expression in the human colon, prior to the present 
study. 
Herein, al1 molecules analyzed were strongly 
detected throughout the epithelium of both the ileum and 
colon beginning at 12 wks (not shown; see also Fig. 3), 
when villogenesis is already underway (Ménard, 1989; 
Ménard and Calvert, 1991; Ménard and Beaulieu, 1994). 
Between 15 and 17 wks of gestation, we observed in 
both gut segments that the epithelial localization of some 
of the Bcl-2 homologs underwent a gradual process of 
compartimentalization, which was found to culminate by 
mid-gestation (as illustrated in Figs. 1, 2). We have 
previously shown that this compartimentalization of 
epithelial Bcl-2 homolog expression coincides with the 
mid-gestation emergence of villus-tip apoptotic cells, 
whereas apoptotic enterocytes are not evidenced in prior 
developmental stages (Vachon et al., 2000). 
For the ileum (Fig. l), epithelial stainings for Bcl- 
XL (Fig. lA), Bag-1 (Fig. lC), Bcl-2 (Fig. ID) and Bak 
(Fig. 1E) were detected as decreasing crypt-to-villus 
gradients. In contrast to these, Mcl-1 staining was found 
concentrated in villus cells, but poorly detectable in 
crypt cells (Fig. 1B). Bax remained detectable 
throughout the epithelium (Fig. 1F). Note that, by 18 
wks, staining for Bcl-2 had become very weak (Fig. ID), 
whereas that for Bad was below detectable levels (not 
shown; see next section). 
For the colon (Fig. 2), epithelial stainings for Bcl-XL 
(Fig. 2A) and Bak (Fig. 2E) were detected as slightly 
decreasing crypt-to-villus gradients, whereas those for 
Bag-1 (Fig. 2C), Bcl-2 (Fig. 2D) and Bax (Fig. 2F) were 
observed throughout the epithelium. Mcl-1 staining was 
found weak at the apex of villi and base of crypts, but 
otherwise strongly expressed in the rest of the epithelium 
(Fig. 2B). Note that, beginning around 15 wks, staining 
for Bad had become below detectable levels (not shown, 
see next section). 
The differential crypt-villus patterns of Bcl-2 
homolog expression remained unchanged from 18 to 20 
wks in both the ileum and colon. However, the 
comparison of the stainings between the two segments at 
mid-gestation revealed sharp differences in the case of 
some homologs. For instance, the relative staining 
intensity for Bcl-X (Fig. lA, 2A), Bag-1 (Figs. lC, 
2C), Bcl-2 (Figs. l b ,  2D) and Bak (Figs. lE, 2E) was 
clearly stronger in the colon than in the ileum. 
Conversely, Bag-1 (Figs. lC, 2C) and Bcl-2 (Figs. ID, 
2D) exhibited crypt-villus decreasing gradients of 
expression in the ileum but not in the colon, 
whereas Mcl-1 (Fisg. lB ,  2B) displayed differing 
compartimentalizations between the two segments. In 
contrast to such differences between the two gut 
segments, we found that the staining patterns for Bcl-2 
homologs (and the Bag-1 protein) in the proximal, 
median and dista1 portions of the mid-gestation colon 
were highly similar, if not identical (not shown). 
Finally, it is of note that staining for al1 Bcl-2 
homologs analyzed herein (including the non- 
homologous molecule Bag-1) was predominantly 
detected in the intestinal epithelium at al1 developmental 
stages studied (9-20 wks), mesenchymal cellular 
elements in both segments being weakly andlor sparsely 
stained depending on the molecule analyzed (Figs. 1,2). 
Epithelial expression levels of Bcl-2 homologs during 
morphogenesis of the ileum and colon 
To further characterize the differences in staining 
intensities and crypt-villus axis localization of Bcl-2 
homologs between the ileum and colon, we then 
investigated the developmental protein expression levels 
of these same homologs. Immunoblot analyses of lysates 
from mucosa1 scrappings (12 to 20 wks) demonstrated, 
in both gut segments, the protein expression of al1 
molecules analyzed (Fig. 3). Thus, Bcl-2 (-26 kDa), 
Bcl-XL (-28-30 kDa), Bag-1 (-32-34 kDa), Mcl-1 (-39- 
42), Bax (-21 kDa), Bak (-25-28 kDa) and Bad (-28-32 
kDa) were detected at al1 developmental stages studied 
as protein bands migrating at their previously reported 
relative molecular weights (Krajewski et al., 1994a-c, 
1995, 1996; Takayama et al., 1995; Krajewska et al., 
1996; Packham et al., 1997; Adams and Cory, 1998; 
Metcalfe et al., 1999; Boucher et al., 2000; Vachon et al., 
2000). To characterize the developmental epithelial 
expression profiles of each molecule studied in relation 
to the morphogenesis of the ileum and colon, their 
relative epithelial expression levels were evaluated by 
comparison with a reference protein, cytokeratin 18 
(K18). The densitometric data presented in Figures 4-8 
show that the relative epithelial expression levels of al1 
Bcl-2 homologs analyzed (including the Bag-1 protein) 
are differentially modulated in parallel to the 
morphogenesis of both the ileum and colon. 
In the case of the ileum (Figs. 3A, 4-5), Bcl-2 levels 
remained stable between 12 and 17 weeks, but decreased 
sharply around 18-19 wks (Figs. 3A, 4A), thus resulting 
in a significant -36% overall reduction (Fig. 8A). 
Similarly, Bag-1 expression levels gradually decreased 
Flg. 1. Epithelial localization of Bcl-2 
homologs in the human ileum at mid- 
gestation. Representative immuno- 
fluorescence micrographs of cryosections 
of human fetal ileums at 18 (B. F), 19 (A, 
D) or 20 weeks of gestation stained for 
the detection of Bcl-XL (A), Mcl-1 (B), 
Bag-1 (C), Bcl-2 (D), Bak (E) and Bax (F). 
Note in (A), (D) and (F) that the primary 
antibodies cross-reacted with gobletl 
mucus cells of specimens used, as 
evidenced by bright spots sparsely 
distributed within the epithelium. C: crypt 
e: simple columnar epithelium; V: villus 
Bars: B, F. 90 pm; A, D, 100 pm; E, F 
125 pm. 
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Flg. 2. Epithelial localization of Bcl-2 hornologs in 
the human colon at mid-gestation. Representative 
irnrnunofluorescence micrographs of cryosecüons of 
hurnan fetal colons at 18 (A,B), 19 (C, D) or 20 (E,F) 
weeks of gestation stained for the detection of Bcl- 
X, (A), Mcl-1 (B). Bag-1 (C), Bcl-2 (D), Bak (E) and 
Bax (F). Note in (D) that the primary antibodies 
cross-reacted with goblet/mucus cells of specimens 
used, as evidenced by bright spots sparsely 
distributed within the epitheliurn. C, crypt; e, simple 
m colurnnar epitheliurn; V: villus. Bar: 100 pm. 
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between 12 and 20 wks (Figs. 3A, 4C), resulting in a 
significant -36% overall reduction (Fig. 8A). Although 
Bcl-XL increased between 12 and 16 wks, its levels 
decreased in subsequent stages (Figs. 3A, 4B), thus 
resulting in a slight (and non-significant) -18% overall 
decrease (Fig. 8A). Mcl-1 steadily increased between 12 
and 20 wks (Figs. 3A, 4D), resulting in a significant 
-230% overall increment (Fig. 8A). Finally, Bax levels 
(Figs. 3A, 5A) underwent an overall non-significant 
decrease of -20%, whereas Bak (Fig. 3 4  5B) and Bad 
(Figs. 3A, 5C) decreased significantly throughout ileum 
development, resulting in overall decreases of -70% and 
-90% respectively (Fig. 8A). Note that the weak 
detection of the Bad protein by mid-gestation (Fig. 3A) 
correlated with our failure to visualize its epithelial 
localization by immunofluorescence at the same stages 
(see previous section). 
In the case of the colon (Figs. 3B, 6-7), the 
expression levels of Bcl-2 (Figs. 3B, 6A), Bag-1 (Figs. 
3B, 6C), Mcl-1 (Figs. 3B, 6D) and Bak (Figs. 3B, 7B) 
gradually increased between 12 and 20 wks, resulting in 
significant overall increments of -194%, -79%, -80% 
lleum 
and -110% respectively (Fig. 8B). Bcl-XL (Figs. 3B, 
6B) decreased sharply between 14 and 15 wks in order 
to increase again around 18-19 wks, resulting 
nonetheless in a significant overall decrease of -48% 
(Fig. 8A). Similarly, Bad (Figs. 3B, 7C) decreased 
sharply around 14 and 15 wks in order to remain at low 
levels throughout subsequent stages, resulting in a 
significant overall decrease of -83% (Fig. 8B). Note that 
the weak detection of the Bad protein by mid-gestation 
(Fig. 3B) correlated with our failure to visualize its 
epithelial localization by immunofluorescence at the 
same stages (see previous section). Finally, Bax levels 
decreased ,slightly between 12 and 20 wks (Figs. 3B, 
7A), representing a non-significant -25% overall 
decrease (Fig. 8B). 
Establishment by mid-gestation of distinct epithelial Bcl-2 
homolog expression profiles for the ileum and colon 
Although the observed developmental modulations 
of Bcl-2 homolog expression appeared to parallel the 
morphogenesis of both the ileum and colon, we found 
Bak 
Bad 
Fig. 3. Protein expression levels of Bcl-2 homologs duflng deveiopment oí the human ileum and colon. Repr+enWre Westem bkrt anatyses of Bcl-2, 
Bci-&, üag-1, Mcl-1, Bax, Bak, Bad and cytokerafin 18 (KlB) expression levels from muoosai scrapplngs oí human fetal ileums Ulr) and colons (8) at 
12-14 (lane l ) ,  15-16 (lane 2), 17-18 (lam, 3) and 19-20 ( h e  4) weeks of gestation. Total proteins (50 pghdl) were sep8tatef.i by 8WPAGE under 
reducing conditions, electro-ed onto nilrooelluloge rnembranes, and then probed with specific antibodigs for the detectfon of W - 2  (-26 kDa), 
edx, (-2830 k h ) ,  üag-1 (-32-34 kDa), Mcl-1 (-39-42 kDa), Bax (-21 kDa), Bak (-25-28 kDa), or Bad (-28-32 kDa). Detection of K18 (-5055 kDa) 
was u& as control of protein quantities analped per each dewlopmental age group. 
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Table 1. Distinct relative epithelial Bcl-2 homolog expression profiles 
beiween the ileum and colon at mid-gestation. 
HOMOLOG ILEUM COLON 
(ratio hornolog/K18) (ratio hornolog/K18) 
-- -- 
Bcl-2 0.488510.0352 2.1 14310.2765* 
Bcl-XL 0.21 44i0.0249 0.403310.0253* 
Bag-1 0.4936i0.0705 1 .O361 10.0567 
Mcl-1 1.347610.0953 1.558210.1 138 
Bax 1.934010.1149 0.753320.1 61 4* 
Bak 0.292010.0058 1.1 66710.21 59* 
Bad 0.0391 10.0067 0.1 86710.0087" 
Data represent meansiSEM for at least three (m 3) specimens per gut 
segment. Total proteins from rnucosal scrappings of ileum or colon 
specimens, aged beiween 18 and 20 wks of gestation, were separated 
and probed as represented in Figure 3, and then scanned by laser 
densitometry. Total peak areas (AU x mrn) were determined for anti- 
apoptotic (Bcl-2, Bcl-XL, Bag-1, Mcl-1) and pro-apoptotic Bak and 
Bad) proteins in order to establish their relative epithelial expression 
levels in comparison to those of cytokeratin 18 (KlE), as expressed by 
the ratios 'homologlK18". Asterisks (*) indlcate statistically significant 
(0.001s a+ 0.01) d'ierences between the colon and ileum. 
Weeks (post-fertJlhatlon) 
that such modulations could differ sharply in tendencies 
(Le. up or ddwn-regulation) between the two gut 
segments (Figs. 3, 8). For instance, Bcl-2, Bag-1 and 
Bak levels increased between 12 and 20 wks in the colon 
(Figs. 3B, 8B), but the levels of these same homologs 
decreased in the ileum throughout the same 
developmental period (Figs. 3A, 8A). However, not al1 
homologs behaved in such a differential fashion: the 
expression levels of Bcl-XL, Mcl-1, Bax and Bad 
underwent developmental modulations with similar 
tendencies in both gut segments, albeit with differing 
orders of magnitude (Figs. 3A, 8A vs Figs. 3B, 8B). 
Nonetheless, the differential tendencies andlor orders of 
magnitude of these developmental modulations resulted 
by mid-gestation in the establishment of distinct Bcl-2 
homolog expression profiles for the ileum and colon 
(Table 1; Fig. 3A, lane 4 vs Fig. 3B, lane 4). Indeed, the 
relative epithelial expression levels of nearly al1 
molecules analyzed at 18-20 wks contrasted significantly 
between the two segments (Table 1). 
Flg. 4. Relative epithelial 
expression levels of anti-apoptotic 
Bcl-2 homologs during 
develo~ment of the human ileum. 
12-14 15-16 17-18 19-20 
Weeks (post-fertillzatlon) 
12-14 15-16 17-18 19-20 
Weeks (post-fertilitatlon) 
~elative xpression levels of Bcl- 
2 (A), Bcl-XL (B), Bag-1 (C) and 
Mcl-1 (D) during development of 
the human ileum, in comparison 
to cytokeratin 18 (K18). Total 
proteins from mucosa1 scrappings 
were separated and probed as 
represented in Fig. 3, and then 
scanned by laser densitometry. 
Total peak areas (AU x mm) were 
determined for each protein 
analyzed at 12-1 4, 15-1 6, 17-1 8 
and 19-20 weeks of gestation 
(post-fertilization), in order to 
establish the ratios Bci-2/K18 (A), 
Bcl-XUKl8 (B), Bag-1lK18 (C) 
and Mcl-1IKl8 (D). Each column 
represents the mean~SEM of at 
least three different specimens 
(nz 3) analyzed per 
developmental age group; 
statistically significant (0.001 S pr  
0.01) differences are indicated by 
an asterisk (*). 
Bcl-2 homologs in the developing human gut 
Weeks (post-fertilization) 
Weeks (post-fertilization) 
12-14 15-16 17-18 19-20 
Weeks (post-fertlllzation) 
Discussion 
In this study, we examined the question whether 
segment-specific control mechanisms of enterocytic 
apoptosis are acquired early during human gut 
development. To do so, we investigated the localization 
and expression of six Bcl-2 homologs (Bcl-2, Bcl-Xb 
Mcl-1, Bax, Bak, Bad), and one nonhomologous 
associated molecule (Bag-1), in the developing human 
ileum and colon between 12 and 20 wks of gestation. We 
found that the relative epithelial expression levels of 
Bcl-2 homologs undergo modulations during 
morphogenesis of the ileum and colon; however, the 
developmental profiles observed contrast significantly 
between the two gut segments. We also found that, 
beginning at 18 wks, the epithelial expression of Bcl-2 
homologs exhibits differential patterns (or gradients) 
along the crypt-villus axis of both the ileum and colon; 
however, such patterns of expression differed between 
the two segments for some of the homologs studied. 
Finally, we found that the relative epithelial expression 
levels of Bcl-2 homologs differed greatly between the 
ileum and colon at 18-20 wks. Hence, by mid-gestation, 
the small intestine and colon exhibit distinct patterns of 
epithelial Bcl-2 homolog localization along their crypt- 
villus axis, as well as distinct epithelial Bcl-2 homolog 
expression profiles. 
Previous studies in rodents (Krajewski et al., 1994a- 
c, 1995, 1996; Merritt et al., 1995; Wilson and Potten, 
1996; Hirose et al., 1997; Aschoff et al., 1999; Pritchard 
et al., 1999) and man (Hockenbery et al., 1991; LeBrun 
et al., 1993; Lu et al., 1993, Hague et al., 1994; 
Krajewski et al., 1994c, 1995, 1996; Moss et al., 1996; 
Wilson et al., 2000) have shown differences in the 
expression of Bcl-2 homologs between the adult small 
and large intestines. The present study provides further 
documentation on segment-specific patterns of epithelial 
localization and expression of Bcl-2 homologs for the 
human small intestine and colon. Furthermore, our data 
show that the expression of Bcl-2 homologs is 
modulated differentially during gut development, 
resulting in the establishment by mid-gestation of 
distinct epithelial Bcl-2 homolog expression profiles 
between the two adjacent gut segrnents. Because Bcl-2 
homologs constitute a critica1 checkpoint in the 
regulation of apoptosis, it has been suggested that 
Rg. 5. Relative epithelial expression levels of pro-apoptotic Bcl-2 homologs 
during development of the human ileum. Relative expression levels of Bax 
(A), Bak (B) and Bad (C) during development of the human ileum, in 
comparison to cytokeratin 18 (K18). Total proteins fmm mucosal scrappings 
were separated and probed as represented in Fig. 3, and then scanned by 
laser densitometry. Total peak areas (AU x mm) were determined for each 
protein analyzed at 12-14, 15-1 6, 17-1 8 and 19-20 weeks of gestation 
(post-fertilization), in order lo establish the ratios BaxJK18 (A), BaklKl8 (B) 
and Bad/K18 (C). Each column represents the mean i SEM of at least 
three different specimens (nz 3) analyzed per developmental age group; 
statistically significant (0.001s ps 0.01) diierences are indicated by an 
asterisk (*). 
Bcl-2 homologs in the developing human gut 
differential enterocytic Bcl-2 expression profiles may 
reflect the existence of segment-specific controls of 
intestinal epithelial apoptosis (Potten, 1992, 1997; Jones 
and Gores, 1997). Indeed, the balance of pro-versus anti- 
apoptotic Bcl-2 homologs, as well as their activities, 
determines in good part how cells respond to death 
and/or survival signals (Gajewski and Thompson, 1996; 
Reed et al., 1996a; Adams and Cory, 1998; Evan and 
Littlewood, 1998; Saini and Walker, 1998). To this 
effect, the observations in rodents that small intestinal 
cells display greater sensitivity to chemotherapeutic 
drug- or irradiation-induced apoptosis than colonic cells 
(Hall et al., 1994; Kiefer et al., 1995; Merritt et al., 1995; 
Hirose et al., 1997; Pritchard et al., 1999) strenghten the 
hypothesis that differences in Bcl-2 homolog expression 
correlate with distinct control mechanisms of apoptosis 
for the small intestine and colon (Potten, 1992, 1997; 
Jones and Gores, 1997). The need for such segment- 
specific distinctiveness in the regulation of cell survival 
is thought to be related to the nature of the luminal 
contents to which the intestinal epithelium is exposed to, 
along the proximal-dista1 axis of the gut: indeed, the 
colonic epithelium is exposed to an environment more 
pro-apoptotic than the small intestinal epithelium and 
thus would require greater resistance to apoptosis 
(Binder et al., 1991; Cobb and Williamson, 1991; Potten, 
1992, 1997; Jones and Gores, 1997; Liu et al., 1999). In 
light of al1 of these considerations, our data altogether 
suggest that bowel segment-specific control mechanisms 
of enterocytic apoptosis are acquired early during fetal 
life in man. 
Another aspect of our findings concerns our 
observation that the ileum and colon already display 
distinct Bcl-2 homolog crypt-villus localization and 
expression profiles by mid-gestation, even though the 
colon has yet to acquire its adult-like properties. On the 
one hand, the Bcl-2 homolog epithelial staining patterns 
observed herein for the mid-gestation ileum correlate 
well with (or confirm) those previously reported in the 
fetal (LeBrun et al., 1993; Lu et al., 1993; Vachon et al., 
12-14 lb16 17-18 19-20 
Weeks (post-fertilization) 
12-14 15-16 17-18 19-20 
Weeks (posf.fertlllzaüon) 
Weeks (post-fertilization) 
Flg. 6. Relative epithelial 
expression levels of anti- 
apoptotic Bcl-2 homologs during 
development of the human 
colon. Relative exDression levels 
of Bcl-2 (A), BCI-X~ (B), Bag-1 
(C) and Mcl-1 (D) during 
development of the human 
colon, in comparison to 
cytokeratin 18 (K18). Total 
proteins from mucosa1 
scrappings were separated and 
probed as represented in Fig. 3, 
and then scanned by laser 
densitometry. Total peak areas 
(AU x mm) were determined for 
each protein analyzed at 12-1 4, 
15-16, 17-18 and 19-20 weeks 
of gestation (post-fertilization), in 
order to establish the ratios Bcl- 
21K18 (A), Bcl-XUK18 (B), Bag- 
1/K18 (C) and Mcl-1/K18 (D). 
Each column represents the 
mean t SEM of at least three 
different specimens (n+ 3) 
analyzed per developmental age 
group; statistically significant 
10.001s DS 0.01) differences are 
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12-14 15-16 17-18 19-20 
Weeks (post-fertilizatlon) 
12-14 15-16 17-18 19-20 
Weeks (post-fertllization) 
12-14 1616 17-18 19-20 
Weeks (post-ferlllizatlon) 
2000) and adult human small intestine (Hockenbery et 
al., 1991; Lu et al., 1993; Krajewski et al., 1994c, 1995, 
1996; Moss et al., 1996), indicating that adult-like small 
intestinal Bcl-2 homolog expression profiles are 
acquired early in man, as is the case for other enterocytic 
cellular processes and functions (Ménard, 1989; Cobb 
and Williamson, 1991; Ménard and Calvert, 1991; 
Ménard and Beaulieu, 1994; Vachon et al., 2000). On the 
other hand, the stainings shown herein for Bcl-2, Bcl- 
X , Mcl-1, Bax and Bak in the mid-gestation colon 
diSfer from those already observed in the adult 
counterpart (Lu et al., 1993; Krajewski et al., 1994c, 
1995, 1996; Krajewska et al., 1996; Moss et al., 1996; 
Liu et al., 1999). For example, Bcl-2 staining was 
observed throughout the epithelium of the 18-20 wks old 
fetal colon (Fig. 2D), whereas it exhibits a decreasing 
crypt-to-surface gradient of expression in the adult (Lu 
et al., 1993; Krajewski et al., 1995; Krajewska et al., 
1996). Similarly, Bak epithelial localization was found 
as a decreasing gradient along the crypt-villus axis of the 
mid-gestation colon (Fig. 2E), whereas it is 
compartimentalized to surface and upper mid-crypt cells 
in the adult (Krajewski et al., 1996; Moss et al., 1996; 
Liu et al., 1999). Hence, such apparent differences 
between the mid-gestation and adult colon suggest that 
further developmental changes in colonic Bcl-2 homolog 
expression profiles and apoptotic control mechanisms 
may occur between 30 wks and birth, as the large 
intestine undergoes its final maturation to acquire its 
adult morphological and functional features. In support 
of this, it is noteworthy that a recent study has provided 
evidence for differences in epithelial sensitivity to 
apoptosis and Bak expression between the right and left 
adult human colon (Liu et al., 1999), whereas we 
observed no differences in the staining pattems of Bcl-2 
homologs between the proximal, median and dista1 
portions of the mid-gestation colon. 
In conclusion, the present findings provide new 
insights into the developmental establishment of putative 
segment-specific control mechanisms of epithelial cell 
apoptosis in the human gut, whereby the expression of 
Bcl-2 homologs is modulated differentially in order to 
establish, by mid-gestation, distinct Bcl-2 homolog 
epithelial localization and expression profiles for the 
small intestine and colon. The developmental processes 
responsible for such early acquirement of segmental 
distinctions in intestinal Bcl-2 homolog expression in 
Fig. 7. Relative epithelial expression levels of pro-apoptotic Bcl-2 homologs 
during development of the human colon. Relative expression levels of Bax 
(A), Bak (B) and Bad (C) during development of the human colon, in 
comparison to cytokeratin 18 (K18). Total proteins from mucosa1 scrappings 
were separated and probed as represented in Fig. 3, and then scanned by 
laser densitometry. Total peak areas (AU x mm) were determined for each 
protein analyzed at 12-14, 15-16, 17-18 and 19-20 weeks of gestation (post- 
fertilization), in order to establish the ratios Bax/K18 (A), BaMK18 (B) and 
BadlK18 (C). Each column represents the mean i SEM of at least three 
different specimens (nz 3) analyzed per developmental age group; statistically 
signiñcant (0.001 a ps 0.01) differences are indicated by an asterisk (*). 
Bcl-2 homologs in the developing human gut 
Homolog Homolog 
Flg. 8. Dierential modulations of epithelial Bcl-2 homolog expression levels during development of the human ileum and colon. Total proteins (50 
pghnrell) from mucosa1 scrappings of human fetal ileums (A) and colons (B) at 12-14 and 19-20 weeks (wks) were separated by SDS-PAGE under 
reducing conditions, electrotransferred onto nitrocellulose membranes, probed with specific antibodies for the detection of Bcl-2, Bcl-XL, Bag-1, Mcl-1 , 
Bax, Bak or Bad, and then scanned by laser densitometry. Total peak areas (AU x mm) were determined for each protein analyzed at 12-14 and 19-20 
wks of gestation (post-fertilization), in order to establish the relative increase or decrease of protein expression levels at 19-20 wks, in comparison to 
12-14 wks. Values are expressed as *% of levels at 12-14 wks", where "0%" indicates no differences in protein expression levels between 19-20 and 
12-14 wks. Each column represents the mean I SEM of at least six different specimens (¡.e. na 3 at 12-14 wks, nz 3 at 19-20 wks) per gut segment 
analyzed; statistically significant (0.001 S ps 0.01) diierences are indicated by astensks (*). 
man remain to be understood. For instance, do the 
distinct segmental localization patterns of some of the 
Bcl-2 homologs studied herein reflect upon differential 
functions, for these same homologs, in the precise 
control of epithelial cell survival andlor apoptosis 
between the small intestine and colon? Further analyses, 
using in vitro model systems, will be required to dissect 
at the molecular leve1 the mechanisms which influence 
the functions of Bcl-2 homologs in epithelial cells, 
including their reciprocal homo-Iheterodimerization 
pattems along the crypt-villus axis, as well as to identify 
the exact roles enacted by Bcl-2 homologs themselves in 
the regulation of epithelial programmed cell death and in 
the pathogenesis of disorders that involve dysregulation 
of apoptosis. 
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